<DOC>
	<DOCNO>NCT02724618</DOCNO>
	<brief_summary>There grow body evidence explore role curcumin radioprotector radiation-induced injury normal tissue well radiosensitizer tumor cell . The aim study determine efficacy oral nanocurcumin prostate cancer patient undergo radiotherapy .</brief_summary>
	<brief_title>Nanocurcumin Prostate Cancer Patients Undergoing Radiotherapy ( RT )</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Curcumin</mesh_term>
	<criteria>Histologically confirm adenocarcinoma prostate Candidate External Beam Radiotherapy ECOG performance status 02 Patients Metastatic Prostate Cancer Patients Kidney &amp; Liver dysfunction Gastrointestinal disorder IBD , reflux peptic ulcer Any adverse reaction curcumin</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Curcumin</keyword>
	<keyword>Protection , Radiation</keyword>
	<keyword>Controlled Clinical Trials , Randomized</keyword>
	<keyword>Radiation Therapy</keyword>
	<keyword>Prostate Cancer</keyword>
</DOC>